medigraphic.com
ISSN 0185-6014 (Print)
Órgano oficial de difusión de la Federación Mexicana de Patología Clínica, AC y de la Asociación Latinoamericana de Patología Clínica/Medicina de Laboratorio

2003, Number 1

<< Back Next >>

Rev Mex Patol Clin Med Lab 2003; 50 (1)

Antiphospholipid antibodies syndrome

Barba EJR

Language: Spanish
References: 31
Page: 20-32
PDF size: 105.84 Kb.


ABSTRACT

At present the antiphospholipid syndrome is acquired great interesting of clinical manifestation. This work is a review of principal characteristics.


REFERENCES

  1. von Scheven E et al. Clinical characteristics of antiphospholipid antibody syndrome in children. J Pediatr 1996; 129: 339-345.

  2. Velasco F et al. Síndrome antifosfolípido (SAF): posibles mecanismos patogénicos de trombosis. Sangre 1997; 42(6): 475-481.

  3. Said PB et al. Fisiopatología del síndrome antifosfolípido. Sangre 1993; 38(2): 1131-1138.

  4. Rojas SJ. Revisión síndrome de anticuerpos antifosfolípido. Rev Mex Reumat 1996; 11: 179-185.

  5. Harris EN. Diagnóstico y tratamiento del síndrome antifosfolípido. Ed. Mexicana. Hospital Practice 1995; 4(1): 12-21.

  6. Dunn JP et al. Antiphospholipid antibodies and retinal vascular disease. Lupus 1996; 5: 313-322.

  7. Gharavi AE et al. The syndrome of thrombosis, thrombocytopenia, and recurrent spontaneous abortions associated with antiphospholipid antibodies: Hughes syndrome. Lupus 1996; 5: 343-344.

  8. Hughes GRV. The antiphospholipid syndrome: ten years on. Lancet 1993; 342: 341-344.

  9. Alarcón-Segovia D et al. The concept and classification of antiphospholipid/cofactor syndromes. Lupus 1996; 5: 364-367.

  10. Piette JC. Diagnostic and classification criteria for the antiphospholipid/cofactors syndrome: a “mission impossible”? Lupus 1996; 5: 354-363.

  11. Levy RA. Clinical manifestations of the aPL syndrome. Lupus 1996; 5: 393-397.

  12. Hughes GRV. The antiphospholipid syndrome. Lupus 1996; 5: 345-346.

  13. Wilson WA et al. Genetic risk factors for aPL syndrome. Lupus 1996; 5: 398-403.

  14. Triplett DA. Lupus anticoagulants/antiphospholipid-protein antibodies: the great imposters. Lupus 1996; 5: 431-435.

  15. Lockshin MD. Antiphospholipid antibody syndrome. Rheumatic Disease Clinics of North America 1994; 20(1): 45-59.

  16. Lockshin MD. Pathogenesis of the antiphospholipid antibody syndrome. Lupus 1996; 5: 404-408.

  17. Machin SJ. Platelets and antiphospholipid antibodies. Lupus 1996; 5: 386-387.

  18. Robbins DL et al. Effect of anticardiolipin/ b2-glycoprotein-1 complexes on production of tromboxane A2 by platelets from patients with the antiphospholipid syndrome. J Rheumatol 1998; 25: 51-56.

  19. Branch DW. Criteria for antiphospolipid syndrome: early pregnancy loss, fetal loss, or recurrent pregnancy loss? Lupus 1996; 5: 409-413.

  20. Levine SR et al. Neurological aspects of antiphospholipid antibody syndrome. Lupus 1996; 5: 347-353.

  21. Baca V et al. Cerebral infarction and antiphospholipid syndrome in children. The Journal of Rheumatology 1996; 23: 1428-1431.

  22. Lie JT. Vasculopathy of the antiphospholipid syndromes revisited: thrombosis is the culprit and vasculitis the consort. Lupus 1996; 5: 368-371.

  23. Hofbauer LCh et al. Graves disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996; 23: 1435-1437.

  24. Asherson RA. The catastrophic antiphospholipid syndrome 1996: acute multiorgan failure with antiphospholipid antibodies: a review of 31 patients. Lupus 1996; 5: 414-417.

  25. Hanly JG et al. b2-glycoprotein-1 and anticardiolipin antibody binding to resting and activated cultured human endothelial cells. J Rheumatol 1996; 23: 1543-1549.

  26. Kandiah DA et al. b2-glycoprotein-1: target antigen for autoantibodies in the “antiphospholipid syndrome”. Lupus 1996; 5: 381-385.

  27. Tomas JF et al. Natural anticoagulant proteins and antiphospholipid antibodies in systemic lupus erythematosus. J Rheumatol 1998; 25: 57-62.

  28. Roubey RAS. Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory and diagnosis of the antiphospholipid syndrome. Lupus 1996; 5: 425-430.

  29. Galli M. Non b2-glycoprotein-1 cofactors for antiphospholipid antibodies. Lupus 1996; 5: 388-392.

  30. Koike T et al. Anti b2-glycoprotein-1 antibody: specificity and clinical significance. Lupus 1996; 5: 378-380.

  31. Harris EN et al. Functional effects of anticardiolipin antibodies. Lupus 1996; 5: 372-377.




2020     |     www.medigraphic.com